Interpretable deep learning of myelin histopathology in age-related cognitive impairment.

Journal: Acta neuropathologica communications
Published Date:

Abstract

Age-related cognitive impairment is multifactorial, with numerous underlying and frequently co-morbid pathological correlates. Amyloid beta (Aβ) plays a major role in Alzheimer's type age-related cognitive impairment, in addition to other etiopathologies such as Aβ-independent hyperphosphorylated tau, cerebrovascular disease, and myelin damage, which also warrant further investigation. Classical methods, even in the setting of the gold standard of postmortem brain assessment, involve semi-quantitative ordinal staging systems that often correlate poorly with clinical outcomes, due to imperfect cognitive measurements and preconceived notions regarding the neuropathologic features that should be chosen for study. Improved approaches are needed to identify histopathological changes correlated with cognition in an unbiased way. We used a weakly supervised multiple instance learning algorithm on whole slide images of human brain autopsy tissue sections from a group of elderly donors to predict the presence or absence of cognitive impairment (n = 367 with cognitive impairment, n = 349 without). Attention analysis allowed us to pinpoint the underlying subregional architecture and cellular features that the models used for the prediction in both brain regions studied, the medial temporal lobe and frontal cortex. Despite noisy labels of cognition, our trained models were able to predict the presence of cognitive impairment with a modest accuracy that was significantly greater than chance. Attention-based interpretation studies of the features most associated with cognitive impairment in the top performing models suggest that they identified myelin pallor in the white matter. Our results demonstrate a scalable platform with interpretable deep learning to identify unexpected aspects of pathology in cognitive impairment that can be translated to the study of other neurobiological disorders.

Authors

  • Andrew T McKenzie
    Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gabriel A Marx
    Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Daniel Koenigsberg
    Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Mary Sawyer
    Center for Computational and Systems Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Megan A Iida
    Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Jamie M Walker
    Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA.
  • Timothy E Richardson
    Neuropathology Laboratory, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
  • Gabriele Campanella
    Weill Cornell Medicine, New York, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Johannes Attems
    Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
  • Ann C McKee
    Department of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA.
  • Thor D Stein
    Department of Pathology, Boston University School of Medicine, Boston, MA, 02118, USA.
  • Thomas J Fuchs
    Weill Cornell Medicine, New York, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: gac2010@med.cornell.edu.
  • Charles L White
    Neuropathology Laboratory, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
  • Kurt Farrell
    Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • John F Crary
    Department of Pathology, Nash Family Department of Neuroscience, Department of Artificial Intelligence & Human Health, Neuropathology Brain Bank & Research CoRE, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.